Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
06/2013
06/26/2013EP2606727A1 Compounds with nematicidal activity
06/26/2013EP2606043A1 Pyridazin derivatives as antagonists of the bradykinin b1 receptor
06/26/2013EP2606036A1 New compounds
06/26/2013EP2606035A1 Proces for the synthesis of substituted urea compounds
06/26/2013EP2605652A1 Diketones and hydroxyketones as catenin signaling pathway activators
06/26/2013CN103180313A 有机电致发光装置 Organic electroluminescent device
06/26/2013CN103180312A Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine
06/26/2013CN103180305A Production method for epoxy alcohol compound
06/26/2013CN103180301A 5-iodo-triazole derivatives
06/26/2013CN103180295A 多环四环素化合物 Polycyclic tetracycline compounds
06/26/2013CN103180291A Alkoxyimino derivative and pest control agent
06/26/2013CN103172626A Dye compound
06/26/2013CN103172621A Preparation method of improved quetiapine amino alcohol
06/26/2013CN103172606A Coumarin compound with anti-tumor activity
06/26/2013CN103172605A 3-acetylcoumarin compound having PTP 1B inhibitory activity
06/26/2013CN103172570A Fungicide n-6-membered fused (hetero) aryl-methylene-n-cycloalkyl carboxamide derivatives
06/26/2013CN102112447B HIV integrase inhibitors from pyridoxine
06/26/2013CN101426780B Cyclohexylimidazole lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
06/25/2013US8471014 Process of making gyrase and topoisomerase IV inhibitors
06/25/2013US8470875 Use of parthenolide derivatives as antileukemic and cytotoxic agents
06/25/2013US8470834 AZO-substituted pyridine and pyrimidine derivatives and their use in treating viral infections
06/25/2013CA2725425C Homocysteine synthase inhibitor
06/25/2013CA2588963C 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same
06/25/2013CA2577446C 2-arylcarbamoyl-indoles as cytokine inhibitors
06/25/2013CA2570264C 3-aminoindazoles
06/20/2013WO2013090929A1 Amino quinoline derivatives inhibitors of hcv
06/20/2013WO2013090836A1 Fluorinated estrogen receptor modulators and uses thereof
06/20/2013WO2013090829A1 Estrogen receptor modulators and uses thereof
06/20/2013WO2013090550A1 Novel glycoside compounds
06/20/2013WO2013089212A1 Substituted triazine derivative and pharmaceutical composition containing same
06/20/2013WO2013089168A1 Method for producing neuraminic acid derivative
06/20/2013WO2013088373A1 Amorphous vilazodone hydrochloride, a process for its preparation and pharmaceutical compositions thereof
06/20/2013WO2013087864A1 Strigolactam derivatives as plant growth regulating compounds
06/20/2013WO2013087805A1 Piperazine derivatives and their use as positive allosteric modulators of mglu5 receptors
06/20/2013WO2013087738A1 Novel compounds
06/20/2013WO2013087643A1 1,3,5 -triazine-2-amine derivatives, preparation thereof and diagnostic and therapeutic use thereof
06/20/2013WO2013087577A1 N-(1,2,5-oxadiazol-3-yl), n-(1,3,4-oxadiazol-2-yl), n-(tetrazol-5-yl), and n-(triazol-5-yl) aryl carboxylic acid amides and use thereof as herbicides
06/20/2013WO2013056003A3 Catechol diethers as potent anti-hiv agents
06/20/2013US20130158263 Intermediates for the preparation of hmg coa reductase inhibitors and processes for the preparation thereof
06/20/2013US20130158261 Protease inhibitors
06/20/2013US20130158260 Aminodihydrothiazine derivatives
06/20/2013US20130158259 2-aminopyrimidine modulators of the histamine h4 receptor
06/20/2013US20130158258 2-aminopyrimidine modulators of the histamine h4 receptor
06/20/2013US20130158057 Aminopyrimidine derivatives as lrrk2 modulators
06/20/2013US20130158042 Novel compounds
06/20/2013US20130158037 Compounds and methods for treating tuberculosis infection
06/20/2013US20130158034 Trpm8 antagonists and their use in treatments
06/20/2013US20130158032 Aminopyrimidine derivatives as lrrk2 modulators
06/20/2013US20130158019 Pyrimidine compounds that inhibit anaplastic lymphoma kinase
06/20/2013US20130158009 Piperidinyl-substituted lactams as gpr119 modulators
06/20/2013US20130158006 Aminopyrimidine derivatives as lrrk2 modulators
06/20/2013US20130158005 Pyrimidine derivatives as fak inhibitors
06/20/2013US20130158004 Azetidine Derivatives
06/20/2013US20130158003 Heteroaryl compounds and methods of use thereof
06/20/2013US20130157999 Aminopyrimidine derivatives as lrrk2 modulators
06/20/2013US20130157997 Benzimidazole analogues for the treatment or prevention of flavivirus infections
06/20/2013US20130157971 2'-fluoronucleosides
06/20/2013US20130157375 Compound
06/20/2013CA2857753A1 Strigolactam derivatives as plant growth regulating compounds
06/20/2013CA2857061A1 Novel benzopyran compounds, compositions and uses thereof
06/20/2013CA2857057A1 Fluorinated estrogen receptor modulators and uses thereof
06/19/2013EP2604604A1 Benzofuranyl derivatives used as glucokinase inhibitors
06/19/2013EP2604597A1 Heterocyclic compound and use thereof
06/19/2013EP2604595A1 Triazine derivative and pharmaceutical compound that contains same and exhibits analgesic activity
06/19/2013EP2603504A1 Hepatitis c virus inhibitors
06/19/2013EP2603502A1 4 - aminoquinazolin- 2 - yl - 1 - pyrrazole - 4 - carboxylic acid compounds as prolyl hydroxylase inhibitors
06/19/2013EP2603500A1 Inhibitors of bruton's tyrosine kinase
06/19/2013EP2603496A1 1,4,5,6-tetrahydro-pyrimidin-2-ylamine compounds
06/19/2013EP2603490A1 Novel trpv3 modulators
06/19/2013EP2603218A1 Quinolyl amines as kinase inhibitors
06/19/2013EP2603079A1 Positive allosteric modulators of mglur2
06/19/2013CN1950343B Basic amine compound and use thereof
06/19/2013CN103168029A Salts and polymorphs of sulfamide ns3 inhibitors
06/19/2013CN103159749A Synthesis method for antidepressant drug vilazodone
06/19/2013CN103159748A Preparation and application of 2-(1H-1, 2, 3-triazole-4-group) aniline compounds
06/19/2013CN103159747A Synthetic method of lapatinib
06/19/2013CN103159746A Industrial tegafur synthesizing method
06/19/2013CN103159743A Small-molecule inhibitor compound capable of simultaneously inhibiting VEGFR (vascular endothelial growth factor receptor) and EGFR (epidermal growth factor receptor) receptor kinase families and preparation method thereof
06/19/2013CN103159741A Preparation and application of novel tyrosine kinase inhibitor
06/19/2013CN103159735A Substitutional imidazole kinase inhibitor
06/19/2013CN103159691A Preparing method and application of isothiocyanate compound
06/19/2013CN103159667A 6-guanidyl-2H-isoindole compound as well as preparation method and application thereof
06/19/2013CN102030742B 4-(substituent phenylamino group) quinazoline derivatives used as tyrosine kinase inhibitor
06/19/2013CN101990535B Benzofurane, benzothiophene, benzothiazol derivatives as fxr modulators
06/19/2013CN101072759B Triazole compounds that modulate HSP90 activity
06/18/2013US8466148 1,2-disubstituted heterocyclic compounds
06/18/2013US8466145 Dipeptidyl peptidase IV inhibitors
06/18/2013CA2595218C Indole derivatives having inhibitory activity against sodium-dependent glucose transporter
06/18/2013CA2566898C Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
06/13/2013WO2013086248A1 Photochromic materials that include indeno-fused naphthopyrans
06/13/2013WO2013085954A1 Substituted piperidinyl-carboxamide derivatives useful as scd 1 inhibitors
06/13/2013WO2013085017A1 Pyridone derivative and medicine containing same
06/13/2013WO2013085016A1 Pyridone derivative and medicine containing same
06/13/2013WO2013084770A1 Azole derivative, method for producing azole derivative, intermediate compound, drug for agricultural and horticultural applications, and industrial material protectant
06/13/2013WO2013084241A1 Compounds as inhibitors of renin
06/13/2013WO2013084138A1 Cyclic urea derivatives as androgen receptor antagonists
06/13/2013WO2013084013A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists
06/13/2013WO2013083994A1 Hydantoin derivatives useful as kv3 inhibitors
06/13/2013WO2013083991A1 Novel compounds and their use in therapy
06/13/2013WO2013083775A1 New compounds, pharmaceutical compositions and uses thereof
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 694